Evidence Hub

Evaluation of the Efficacy of an Avocado Oil-Based Lactobacillus rhamnosus Suspension in DNBS-Induced Colitis in Sprague-Dawley Rats

Dharmeshkumar Kheni

Journal of chemical health risks, 2025

Abstract

Introduction: Inflammatory bowel disease (IBD) is a persistent inflammatory condition affecting the gastrointestinal tract (GIT), characterized by a spectrum of symptoms ranging from mild abdominal discomfort and diarrhoea to severe manifestations such as rectal bleeding, anemia, and, in extreme cases, fatal outcomes. Disruption of the gut microbiota, or dysbiosis, plays a key role in the onset and progression of IBD. Although corticosteroids remain a mainstay in treatment, their long-term use is associated with adverse effects, prompting interest in safer alternatives such as probiotics. Objectives: This study aimed to assess the therapeutic efficacy of a Lactobacillus rhamnosus suspension formulated in Avocado oil in a rat model of colitis induced by dinitrobenzene sulfonic acid (DNBS). Methods: Colitis was induced in Sprague-Dawley rats via intra-rectal administration of DNBS (120 mg/kg), followed by a 3-day induction period. Post-induction, animals were randomized into treatment groups receiving either oral dexamethasone (2 mg/kg/day) or L. rhamnosus suspension (3 × 10⁶ CFU/g/day) for 28 consecutive days. Evaluated parameters included changes in body weight, food and water intake, colon weight, histopathological alterations, colonic mucosal damage index (CMDI), and disease activity index (DAI). Biochemical markers analyzed comprised oxidative stress indicators (nitric oxide [NO], malondialdehyde [MDA]), antioxidant enzymes (glutathione [GSH], superoxide dismutase [SOD]),…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free